ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 95 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $305,203 | -59.1% | 57,477 | -26.6% | 0.00% | -100.0% |
| Q2 2023 | $745,932 | +91.0% | 78,272 | +120.5% | 0.00% | – |
| Q1 2023 | $390,467 | -25.7% | 35,497 | +0.0% | 0.00% | -100.0% |
| Q4 2022 | $525,193 | -21.0% | 35,486 | +1.8% | 0.00% | 0.0% |
| Q3 2022 | $665,000 | +75.9% | 34,853 | +96.5% | 0.00% | – |
| Q2 2022 | $378,000 | +14.2% | 17,741 | +2.9% | 0.00% | – |
| Q1 2022 | $331,000 | -9.6% | 17,239 | -2.3% | 0.00% | – |
| Q4 2021 | $366,000 | -63.9% | 17,643 | -58.5% | 0.00% | – |
| Q3 2021 | $1,015,000 | +153.8% | 42,491 | +190.6% | 0.00% | – |
| Q2 2021 | $400,000 | -17.0% | 14,624 | -12.3% | 0.00% | – |
| Q1 2021 | $482,000 | -30.3% | 16,677 | -32.3% | 0.00% | – |
| Q4 2020 | $692,000 | – | 24,618 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,434,232 | $162,443,000 | 13.84% |
| Bain Capital Life Sciences Investors, LLC | 3,979,292 | $76,641,000 | 7.44% |
| Pivotal bioVenture Partners Investment Advisor LLC | 569,041 | $10,960,000 | 5.19% |
| Logos Global Management LP | 1,500,000 | $28,890,000 | 3.75% |
| Omega Fund Management, LLC | 623,836 | $12,015,000 | 2.46% |
| Orbimed Advisors | 6,073,850 | $116,982,000 | 1.90% |
| MPM BioImpact LLC | 258,500 | $4,979,000 | 1.34% |
| 1492 Capital Management LLC | 75,192 | $1,448,000 | 0.77% |
| SECTORAL ASSET MANAGEMENT INC | 219,136 | $4,221,000 | 0.75% |
| EcoR1 Capital, LLC | 895,503 | $17,247,000 | 0.54% |